The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2015

Filed:

Jun. 03, 2011
Applicants:

William Gerwick, La Jolla, CA (US);

Lena Gerwick, La Jolla, CA (US);

Hyuakjae Choi, San Diego, CA (US);

Francisco Villa, La Jolla, CA (US);

Jennifer Smith, San Diego, CA (US);

David C Rowley, Wakefield, RI (US);

Inventors:

William Gerwick, La Jolla, CA (US);

Lena Gerwick, La Jolla, CA (US);

Hyuakjae Choi, San Diego, CA (US);

Francisco Villa, La Jolla, CA (US);

Jennifer Smith, San Diego, CA (US);

David C Rowley, Wakefield, RI (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 307/33 (2006.01); A61K 8/14 (2006.01); A61K 8/37 (2006.01); A61K 8/42 (2006.01); A61K 8/49 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61Q 11/00 (2006.01); C07C 57/54 (2006.01); A61L 27/54 (2006.01); A61L 29/16 (2006.01); A61L 31/16 (2006.01); A61K 8/69 (2006.01); C07C 57/52 (2006.01); C07C 69/732 (2006.01); C07C 233/15 (2006.01);
U.S. Cl.
CPC ...
C07D 307/33 (2013.01); A61F 2310/0097 (2013.01); A61K 8/14 (2013.01); A61K 8/37 (2013.01); A61K 8/42 (2013.01); A61K 8/4973 (2013.01); A61K 9/0019 (2013.01); A61K 9/127 (2013.01); A61Q 11/00 (2013.01); C07C 57/54 (2013.01); A61L 27/54 (2013.01); A61L 29/16 (2013.01); A61L 31/16 (2013.01); A61L 2300/202 (2013.01); A61L 2300/404 (2013.01); A61L 2300/41 (2013.01); A61K 8/69 (2013.01); C07C 57/52 (2013.01); C07C 69/732 (2013.01); C07C 233/15 (2013.01);
Abstract

The invention provides novel compositions based on a structure designated as 'Honaucin A', including Honaucin A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and using them. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used to ameliorate (including to treat or prevent) inflammation. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used to ameliorate (including to treat or prevent) inflammation. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used as bacterial quorumsensing inhibitors. Accordingly, in alternative embodiments the compositions of the invention are used as anti-bacterial agents.


Find Patent Forward Citations

Loading…